Cross-transmission of Acinetobacter junii carrying blaOXA-58 in a neonatal ICU

J Antimicrob Chemother. 2024 Aug 1;79(8):1910-1913. doi: 10.1093/jac/dkae180.

Abstract

Background: Nasal colonization of two preterm infants in our neonatal ICU by Acinetobacter junii carrying the blaOXA-58 carbapenem resistance gene was demonstrated.

Objectives: To study whether the two isolates were identical and to investigate the hypotheses of cross-transmission.

Methods: Antibiotic susceptibility tests of the two isolates were performed by standard diffusion and the MICs of carbapenems determined by the MIC-gradient strip method. The blaOXA-58 gene was detected by PCR. Isolates were compared using SNP analysis performed after WGS. The timelines of the two cases were determined based on the investigations and the study of the patients' records.

Results: The two isolates corresponded to the same strain, with case 1 being the index case, demonstrating cross-transmission to case 2.

Conclusions: Acquisition of the strain was likely due to the recent carbapenem treatment of case 1 and cross-transmission due to the high amount of care administered to the two preterm infants. This is the first description of cross-transmission of A. junii carrying the blaOXA-58 gene.

Publication types

  • Case Reports

MeSH terms

  • Acinetobacter Infections* / microbiology
  • Acinetobacter* / drug effects
  • Acinetobacter* / genetics
  • Acinetobacter* / isolation & purification
  • Anti-Bacterial Agents* / pharmacology
  • Carbapenems / pharmacology
  • Cross Infection* / microbiology
  • Female
  • Humans
  • Infant, Newborn
  • Infant, Premature
  • Intensive Care Units, Neonatal*
  • Male
  • Microbial Sensitivity Tests
  • Polymorphism, Single Nucleotide
  • beta-Lactamases* / genetics

Substances

  • Anti-Bacterial Agents
  • beta-Lactamases
  • Carbapenems

Grants and funding